Endpoints News

Endpoints' Drug Discovery Day is April 15		Read in browser

Thank you for reading, dupa dupackia!

basic

UPGRADE

M T W Thu F

9 April, 2026

John Carroll’s R&D 15 report is back — and this year, he’s bringing some of the industry’s top research chiefs into the conversation to break down what the data means, what’s shifting, and where biopharma R&D is headed. Join us to find out what comes next.

presented by

Forge Biologics A Member of Ajinomoto Bio-Pharma Services

Presenting Your Gene Therapy Manufacturing Plan to Investors: What They Expect in 2026 and How to Deliver It

news

Pulmonary fibrosis biotech Avalyn Pharma files for IPO

PhRMA head Steve Ubl to step down at end of year

Apr 28

12:30 pm ET

Connection ≠ continuity: Rethinking long-term evidence in the age of tokenization

in case you missed it

Gilead takes another big swing at expanding beyond HIV

European VC Jeito gets $1.2B to help private biotechs control their 'destiny'

David Sinclair startup raises $80M for clinical test of anti-aging gene therapy

Insmed shelves Brinsupri in skin disease after mid-stage flop

ADC biotech Sidewinder collects $137M for bispecific approach

News Briefing

Merck adjusts its vaccine supply deal in China; Soleno withdraws EU application

The Hair-Loss Drug Rewriting the Rules of Masculinity

Why obesity drugs work better for some people: these genes hold clues

Long Covid Predicted to Cost OECD Economies $135 Billion a Year

Join us next week for our Drug Discovery Day! There will be separate panels on CRISPR and Alzheimer's disease. Andy Dunn will also chat with Stanford's James Zou, and Ryan Cross will have a one-on-one with Aurora Therapeutics CEO Ed Kaye. See you then!